Phase Forward to Present at the William Blair Small Cap Growth Stock Conference

The Phase Forward presentation is scheduled for Tuesday, October 7, 2008 at 1:20 p.m. ET. The presentation will be webcast live and will be available by visiting the Investors section of the company's website at www.phaseforward.com. The webcast will be archived on the company's website for 30 days after the conference ends.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm(TM), phase I clinic automation (LabPas(TM), clinical data management (Clintrial(TM), clinical trials signal detection (CTSD(TM), strategic pharmacovigilance (Empirica Signal(TM) and Signal Management, adverse event reporting (Empirica Trace(TM), applied data standards (WebSDM(TM) and Web-integrated interactive voice response systems (Clarix(TM). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.

SOURCE: Phase Forward Incorporated

Public Relations CHEN PR, Inc. Barbara Heffner, 781-672-3112 bheffner@chenpr.com or Investor Relations Integrated Corporate Relations Timothy Dolan, 617-956-6727 tdolan@icrinc.com